• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外膜肺氧合支持下心内直视术后患者乳酸的早期动态变化与死亡率相关:一项回顾性观察研究。

The early dynamic behavior of lactate is linked to mortality in postcardiotomy patients with extracorporeal membrane oxygenation support: A retrospective observational study.

作者信息

Li Cheng-Long, Wang Hong, Jia Ming, Ma Ning, Meng Xu, Hou Xiao-Tong

机构信息

Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China.

Department of Echocardiography, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China.

出版信息

J Thorac Cardiovasc Surg. 2015 May;149(5):1445-50. doi: 10.1016/j.jtcvs.2014.11.052. Epub 2014 Nov 24.

DOI:10.1016/j.jtcvs.2014.11.052
PMID:25534305
Abstract

OBJECTIVE

Extracorporeal membrane oxygenation (ECMO) is used to support postcardiotomy cardiogenic shock patients. Elevated serum lactate levels might reflect hypoxia in the tissues, which is associated with mortality in critically ill patients. This study examined the association between the early dynamic behavior of lactate and mortality after ECMO support.

METHODS

We included 123 adult patients who had undergone cardiac surgery and received venous-arterial ECMO implantation to treat refractory postcardiotomy cardiogenic shock. The dynamic behaviors of lactate within 6 hours and 12 hours after the beginning of the ECMO support were incorporated into 2 regression models.

RESULTS

A total of 56% of the patients were successfully weaned from ECMO support. The in-hospital mortality was 65.9% overall. Univariate and multivariate analyses indicated that age (odds ratio [OR]: 1.1 in the 6-hour model; 1.1 in the 12-hour model), gender (female; OR: 5.6 in the 6-hour model; 7.7 in the 12-hour model), mean lactate concentration (OR: 1.1 in the 6-hour model; 1.2 in the 12-hour model) and lactate clearance (OR: 0.5 in the 6-hour model; 0.1 in the 12-hour model) were reliable predictors (P < .05) of in-hospital mortality. The mean lactate concentration (C statistic: 0.71) and lactate clearance (C statistic: 0.72) 12 hours after the initiation of ECMO support provided better prognostic guidance. The mean lactate concentration (OR: 1.2) and lactate clearance (OR: 0.3) were able to predict successful weaning from ECMO in the 12-hour model only.

CONCLUSIONS

In addition to age and gender (female), early lactate behaviors, particularly lactate clearance, after ECMO support are highly associated with in-hospital mortality in postcardiotomy patients. Additionally, early lactate behavior is also predictive of successful weaning from ECMO.

摘要

目的

体外膜肺氧合(ECMO)用于支持心脏术后心源性休克患者。血清乳酸水平升高可能反映组织缺氧,这与危重症患者的死亡率相关。本研究探讨了乳酸早期动态变化与ECMO支持后死亡率之间的关联。

方法

我们纳入了123例接受心脏手术并接受静脉 - 动脉ECMO植入以治疗难治性心脏术后心源性休克的成年患者。将ECMO支持开始后6小时和12小时内乳酸的动态变化纳入2个回归模型。

结果

共有56%的患者成功脱离ECMO支持。总体住院死亡率为65.9%。单因素和多因素分析表明,年龄(比值比[OR]:6小时模型中为1.1;12小时模型中为1.1)、性别(女性;OR:6小时模型中为5.6;12小时模型中为7.7)、平均乳酸浓度(OR:6小时模型中为1.1;12小时模型中为1.2)和乳酸清除率(OR:6小时模型中为0.5;12小时模型中为0.1)是住院死亡率的可靠预测因素(P <.05)。ECMO支持开始12小时后的平均乳酸浓度(C统计量:0.71)和乳酸清除率(C统计量:0.72)提供了更好的预后指导。平均乳酸浓度(OR:1.2)和乳酸清除率(OR:0.3)仅在12小时模型中能够预测成功脱离ECMO。

结论

除年龄和性别(女性)外,ECMO支持后早期乳酸变化情况,尤其是乳酸清除率,与心脏术后患者的住院死亡率高度相关。此外,早期乳酸变化情况也可预测能否成功脱离ECMO。

相似文献

1
The early dynamic behavior of lactate is linked to mortality in postcardiotomy patients with extracorporeal membrane oxygenation support: A retrospective observational study.体外膜肺氧合支持下心内直视术后患者乳酸的早期动态变化与死亡率相关:一项回顾性观察研究。
J Thorac Cardiovasc Surg. 2015 May;149(5):1445-50. doi: 10.1016/j.jtcvs.2014.11.052. Epub 2014 Nov 24.
2
Outcomes after peripheral extracorporeal membrane oxygenation therapy for postcardiotomy cardiogenic shock: a single-center experience.体外膜肺氧合治疗心脏手术后心源性休克的结果:单中心经验。
J Surg Res. 2013 May;181(2):e47-55. doi: 10.1016/j.jss.2012.07.030. Epub 2012 Aug 1.
3
[Extracorporeal membrane oxygenation for the treatment of refractory cardiogenic shock in adults: strategies, results, and predictors of mortality].[体外膜肺氧合治疗成人难治性心源性休克:策略、结果及死亡预测因素]
G Ital Cardiol (Rome). 2014 Oct;15(10):577-85. doi: 10.1714/1672.18312.
4
Creatine kinase isoenzyme MB relative index as predictor of mortality on extracorporeal membrane oxygenation support for postcardiotomy cardiogenic shock in adult patients.肌酸激酶同工酶MB相对指数作为成人心脏术后心源性休克体外膜肺氧合支持下死亡率的预测指标
Eur J Cardiothorac Surg. 2006 Oct;30(4):617-20. doi: 10.1016/j.ejcts.2006.07.016. Epub 2006 Aug 28.
5
Blood Lactate as a Reliable Marker for Mortality of Pediatric Refractory Cardiogenic Shock Requiring Extracorporeal Membrane Oxygenation.血乳酸作为需要体外膜肺氧合的小儿难治性心源性休克死亡率的可靠标志物。
Pediatr Cardiol. 2019 Mar;40(3):602-609. doi: 10.1007/s00246-018-2033-2. Epub 2019 Jan 2.
6
Plasma Free Hemoglobin Is an Independent Predictor of Mortality among Patients on Extracorporeal Membrane Oxygenation Support.血浆游离血红蛋白是接受体外膜肺氧合支持患者死亡率的独立预测指标。
PLoS One. 2015 Apr 22;10(4):e0124034. doi: 10.1371/journal.pone.0124034. eCollection 2015.
7
Extracorporeal membrane oxygenation for refractory cardiogenic shock after cardiac surgery: predictors of early mortality and outcome from 51 adult patients.体外膜肺氧合治疗心脏手术后难治性心源性休克:51 例成人患者早期死亡率和预后的预测因素。
Eur J Cardiothorac Surg. 2010 Feb;37(2):328-33. doi: 10.1016/j.ejcts.2009.07.033. Epub 2009 Sep 12.
8
Extracorporeal membrane oxygenation support in refractory cardiogenic shock: treatment strategies and analysis of risk factors.难治性心源性休克的体外膜肺氧合支持:治疗策略及危险因素分析
Artif Organs. 2014 Jul;38(7):E129-41. doi: 10.1111/aor.12317. Epub 2014 May 20.
9
Venoarterial extracorporeal membrane oxygenation for postcardiotomy shock: Risk factors for mortality.体外膜肺氧合在心脏手术后休克中的应用:死亡率的危险因素。
J Thorac Cardiovasc Surg. 2018 Nov;156(5):1894-1902.e3. doi: 10.1016/j.jtcvs.2018.05.061. Epub 2018 Jun 4.
10
Lactate and lactate clearance as valuable tool to evaluate ECMO therapy in cardiogenic shock.乳酸和乳酸清除率作为评估心源性休克中 ECMO 治疗的有价值工具。
J Crit Care. 2017 Dec;42:35-41. doi: 10.1016/j.jcrc.2017.06.022. Epub 2017 Jun 23.

引用本文的文献

1
Analysis of the feasibility of a low-anticoagulation strategy in patients undergoing post-cardiotomy extracorporeal membrane oxygenation: a retrospective cohort study.心脏术后体外膜肺氧合患者低抗凝策略的可行性分析:一项回顾性队列研究
BMC Anesthesiol. 2025 May 30;25(1):275. doi: 10.1186/s12871-025-03153-4.
2
Using a Cardiogenic Shock Classification System for Predicting Postcardiotomy Shock Mortality.使用心源性休克分类系统预测心脏手术后休克死亡率。
JACC Asia. 2025 May;5(5):663-676. doi: 10.1016/j.jacasi.2025.01.007. Epub 2025 Mar 18.
3
CELL FREE DNA-BASED PREDICTION OF PROGNOSIS FOR PATIENTS ON VENO-ARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION.
基于游离DNA对静脉-动脉体外膜肺氧合患者预后的预测
Shock. 2025 Jun 1;63(6):851-856. doi: 10.1097/SHK.0000000000002569. Epub 2025 Feb 26.
4
Intra-aortic balloon pump after VA-ECMO reduces mortality in patients with cardiogenic shock: an analysis of the Chinese extracorporeal life support registry.主动脉内球囊反搏在 VA-ECMO 后降低心源性休克患者的死亡率:中国体外生命支持注册分析。
Crit Care. 2024 Nov 29;28(1):394. doi: 10.1186/s13054-024-05129-1.
5
Phenotyping Refractory Cardiogenic Shock Patients Receiving Venous-Arterial Extracorporeal Membrane Oxygenation Using Machine Learning Algorithms.使用机器学习算法对接受静脉-动脉体外膜肺氧合的难治性心源性休克患者进行表型分析。
Rev Cardiovasc Med. 2024 Aug 22;25(8):303. doi: 10.31083/j.rcm2508303. eCollection 2024 Aug.
6
Outcomes of 576 patients with extracorporeal life support for the treatment of perioperative cardiogenic shock.576例接受体外生命支持治疗围手术期心源性休克患者的治疗结果。
Interdiscip Cardiovasc Thorac Surg. 2024 Sep 4;39(3). doi: 10.1093/icvts/ivae147.
7
Acute kidney injury and cardiogenic shock severity for mortality risk stratification in patients supported with VA ECMO.急性肾损伤和心源性休克严重程度在接受VA体外膜肺氧合支持的患者中用于死亡风险分层。
ESC Heart Fail. 2024 Dec;11(6):3872-3881. doi: 10.1002/ehf2.14967. Epub 2024 Jul 21.
8
The absolute lactate levels versus clearance for prognostication of post-cardiotomy patients on veno-arterial ECMO.用于预测接受静脉-动脉体外膜肺氧合(ECMO)的心脏术后患者预后的绝对乳酸水平与清除率
ESC Heart Fail. 2024 Dec;11(6):3511-3522. doi: 10.1002/ehf2.14910. Epub 2024 Jul 9.
9
Mid-Term Outcome after Extracorporeal Life Support in Postcardiotomy Cardiogenic Shock: Recovery and Quality of Life.心脏术后心源性休克患者接受体外生命支持后的中期结果:恢复情况与生活质量
J Clin Med. 2024 Apr 12;13(8):2254. doi: 10.3390/jcm13082254.
10
Lactate and Lactate Clearance Are Predictive Factors for Mortality in Patients with Extracorporeal Membrane Oxygenation.乳酸和乳酸清除率是体外膜肺氧合患者死亡率的预测因素。
Braz J Cardiovasc Surg. 2024 Mar 1;39(2):e20230091. doi: 10.21470/1678-9741-2023-0091.